Surgical complications in 275 HIV-infected liver and/or kidney transplantation recipients
Jack W. Harbell(University of California, San Francisco), Peter G. Stock(University of California, San Francisco), Douglas W. Hanto(Harvard University), Burc Barin(Emmes (United States)), Thomas C. Pearson(Emory Healthcare), Michelle E. Roland(University of California, San Francisco), Kim M. Olthoff(University of Pennsylvania), Andreas G. Tzakis(Cleveland Clinic), S. Bartlett(University of Maryland, Baltimore), Nicholas N. Nissen(Cedars-Sinai Medical Center), Sander Florman(Mount Sinai Hospital), Jimmy A. Light(MedStar Washington Hospital Center), John J. Fung(University of Chicago)
Cited by 20
Related Papers
Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways
|Nature|1996|1.5k
Banff Schema for Grading Liver Allograft Rejection: An International Consensus Document
|Hepatology|1997|1.3k
Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors
|Liver Transplantation|2010|1.2k
4-1BB Costimulatory Signals Preferentially Induce CD8+ T Cell Proliferation and Lead to the Amplification In Vivo of Cytotoxic T Cell Responses
|The Journal of Experimental Medicine|1997|802
Rational Development of LEA29Y (belatacept), a High-Affinity Variant of CTLA4-Ig with Potent Immunosuppressive Properties
|American Journal of Transplantation|2005|714